Ih Chang

Ih Chang has a strong career in biostatistics, with over 25 years of experience in various leadership roles. Ih currently serves as the Head of Biostatistics at Cerevel Therapeutics, LLC since May 2020. Prior to this, they were the Senior Director of Biostatistics at Biogen for six years from May 2014 to May 2020. Before Biogen, Ih worked as the Director of Biostatistics at Bristol-Myers Squibb from April 2010 to May 2014. Ih also held the position of Director of Biostatistics at Novartis for seven years from August 2003 to April 2010. Ih began their career as a Principal Statistician at Wyeth/Pfizer, where they worked for eight years from May 1995 to August 2003.

Ih Chang holds a Doctor of Philosophy (PhD) degree in Statistics, which was obtained from the University of Wisconsin-Madison. The start year and end year for this educational experience have not been provided.